Specific Diseases of CNS Flashcards
Multiple Sclerosis
Inflammatory, autoimmune disease involving demylination of oligodendrites and neurones in the CNS creating plaques. Mediated by T cells. Cell loss, gliosis and demyelination.
Types of multiple sclerosis
Relapsing-remitting - periods of exaceration then recovery.
Secondary progressive - initial RRMS but disease progresses to no remission periods.
Primary progressive - Never any remission, constant deterioration.
Pathophysiology of MS
T cell mediated demylination. Poor recovery leads to neuronal loss, scarring (plaques).
Risk factors for MS
Genetic Epstein-barr virus (trigger?) Female Smoking Low vit D Adolescent obestity
Complications of MS
Fatigue Spasicity (stiffness + muscle spasm) Ataxia Incontinence Sexual dysfunction Tremor Visual impairments (optic neuritis, diplopia) Pain Poor mobility Poor mental health
Differential diagnosis of MS presentation
Neuromyelitis optica (worse mortality than MS)
SLE
Sarcoidosis
Lyme disease
Vitamin B12 deficiency
Behcet’s syndrome (+oral and genital ulcers, and uveitis)
Neurosyphilis
Uhthoff’s phenomenon
Heat and exercise potentiate ON/MS symptoms (with hot food or in a hot bath vision can decrease)
Optic neuritis symptoms
Partial or total unilateral visual loss
Pain behind the eye, particularly on eye movement
Decrease in acuity of eyesight.
‘Washed-out’ colours
Rarely Argyle Robertson type pupil (lesion near edinger-westphal nucleus)
S+S of MS
Females between 20 and 30 years
Symmetrical or asymmetrical possible.
Symptoms: Optic neuritis Paraesthesia Weird walking Urinary urgency/frequency/retention Constipation Swallowing problems
Signs:
Weakness
Lhermitte’s sign -neck flexion causes shocking pain through trunk.
Brainstem/Cerebellar - ataxia, diplopia, dysarthria, dysphagia
Diagnosis and investigations for MS
Ix = FBC, CRP/ESR, LFT, renal function, HbA1c, TFT, Vit B12, calcium. LP for CSF electrophoresis, CNS MRI, evoked potential test.
MacDonald’s Criteria.
- 2 episodes of a relapse disseminated in time and space lasting greater than 1hr. MRI scan lesion evidence.
- Delayed evoked potentials
- Lumbar puncture CNS has oligocloncal bands of IgG in CSF on electrophoresis.
Treatment of an acute relapse
Methylprednisolone to shorten duration.
Long-term treatment and management of MS
Interferons 1beta and 1alpha or monoclonal antibodies (Alemtuzumab) to reduce relapse occurrence.
Manage complications e.g. Baclofen for spasticity, self-catheterisation.
Stress-free life
Stop smoking
Regular exercise
Sign post to information to patient and carer.
Ramsay Hunt Syndrome
Varicella zoster virus/Herpes simplex 3 reactivated in geniculate ganglion of 7th cranial nerve (facial).
Auricular pain is often the first feature
Ipsilateral facial nerve palsy, forehead NOT spared.
Vesicular rash around the ear/pinna
Vertigo and tinnitus
RX = prednisolone + acyclovir.
Carotid artery stenosis
Bruit
Carotid Doppler
Cause anterior circulation stroke
Treat with carotid endarterectomy
Horner’s syndrome
Constricted pupil (miosis), drooping of the upper eyelid (ptosis), absence of sweating of the face (anhidrosis). Caused by lateral medullary syndrome (from a stroke in posterior inferior cerebral artery), Pancoast tumour in chest, carotid artery dissection.
Pathogenesis of Parkinson’s disease
Chronic, progressive neurodegeneration of dopamine-containing cells in the substantia nigra in basal ganglia. Parkinson’s disease becomes apparent at 50% loss neurones.
Lewy bodies present in remaining neurons.
Effects nigro-striatal pathway signalling.
Cause of Parkinson’s
Genetic predisposition and environmental factors.
Motor clinical features of Parkinson’s disease
Tremor - pill-rolling
Rigidity - cog-wheel in combo with tremor or lead-pipe
Bradykinesia - reduced blinking, swallowing difficulty, difficulty in initiating movements (start hesitation), micrographic handwriting, mask-like expression, drooling, stiff shuffling gait, reduced asymmetrical arm swing, stooped posture, freeze on turning.
Non motor features of Parkinson’s
Constipation Urinary difficulties Depression Dementia Pressure sores
Management of Parkinson’s
MDT
NICE recommends not to start drug until diagnosis confirmed by a specialist.
Vit D supplements
NOTIFY DVLA
L-dopa + dopa-decarboxylase inhibitor. Dopamine agonist (Ropinirole) oral monoamine oxidase B inhibitor
L-dopa
+ dopa-decarboxylase inhibitor to prevent peripheral dopamine decarboxylation. Co-carelopa.
Improve motor symptoms but so much tremor and non-motor symptoms.
Efficacy reduces with time (end-of-dose) but up the dose, increase SE. Also get on and off periods of effect.
SE = IMPULSIVITY!! visual hallucinations, drowsy, painful dystonia, nausea and vomiting.
Oral monamine oxidase B inhibitors
Selegiline.
Early PD
SE = postural hypotension, AF.
oral dopamine agonists
Ropinirole
Delay use of L-dopa so efficacious for longer.
Less effective at improving motor symptoms.
Can get transdermal patches.
Causes of parkinsonism
Lewy body dementia Wilson's disease HIV Repeated head injury (boxers) Huntington's disease First generation antipsychotics Antiemetics
Myasthenia Gravis pathophysiology
Autoimmune disease where B cells and T cells target the nicotinic acetylcholine receptor reducing the number of working post-synaptic Ach receptors.
Epidemiology of Myasthenia Gravis and its associated disease
Women aged 20-35, more likely to have thymus hyperplasia.
Older men over 60 who are more likely to have thymus atrophy to thymoma tumour.
Differential diagnosis of dysphasia
Stroke. Bulbar palsy Pseudobulbar palsy Myasthenia Gravis Oesophageal cancer
Clinical features of myasthenia gravis
Fatiguability on repeated use of muscles.
Speech and swallow bulbar symptoms common in elderly.
Ocular - ptosis, diplopia
Cranial Nerve - Dysarthria, dysphasia, dysphagia, face and jaw weakness. Causes poor chewing, jaw open when chewing, head drop.
Muscle groups affected - face, trunk, limbs.
Difficulty getting out of chair, SOB when lying down.
Normal reflexes but fatigue on repeated testing.
Exacerbating factors for symptoms of myasthenia gravis
Beta-blockers, quinine, opiates, exercise, infection, hypokalaemia, pregnancy, change in climate.
Investigations for myasthenia gravis
Tensilon test.
Serum anti-acetylcholine receptor antibodies, serum anti-muscle-specific kinase antibodies.
Thyroid CT and thyroid function test.
Neurophysiology testing - repetitive nerve stimulation gives decreases response.
Management of myasthenia gravis
Pyridostigmine - anti-cholinesterase helps control symptoms.
2nd line = prednisolone to help relapses and control symptoms. Give bone density protection.
Consider thymectomy.
Ensure no medications are potentiating the disease.